Conjugation of a reactive thiol at the nucleotide binding site for site-specific antibody functionalization

Nathan Alves, Nur Mustafaoglu, Basar Bilgicer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Described here is a UV photo-cross-linking method that utilizes the NBS (nucleotide binding site) for site-specific covalent functionalization of antibodies with reactive thiol moieties (UV-NBSThiol), while preserving antibody activity. By synthesizing an indole-3-butyric acid (IBA) conjugated version of cysteine we site-specifically photo-cross-linked a reactive thiol moiety to antibodies at the NBS. This thiol moiety can then be used as an orthogonally reactive location to conjugate various types of functional ligands that possess a thiol reactive group through disulfide bond formation or reaction with a maleimide functionalized ligand. Our results demonstrate the utility of the UV-NBSThiol method by successfully functionalizing a prostate specific antigen antibody (IgGPSA) with IBA-Thiol and subsequent reaction with maleimide-fluorescein. An optimal UV energy of 0.5-1.5 J/cm2 was determined to yield the most efficient photo-cross-linking and resulted in 1-1.5 conjugations per antibody while preserving antibody/antigen binding activity and Fc recognition. Utilizing the IBA-Thiol ligand allows for an efficient means of site-specifically conjugating UV sensitive functionalities to antibody NBS that would otherwise not have been amenable by the previously described UV-NBS photo-cross-linking method. The UV-NBSThiol conjugation strategy can be utilized in various diagnostic and therapeutic applications with nearly limitless potential for the preparation of site-specific covalent conjugation of affinity tags, fluorescent molecules, peptides, and chemotherapeutics to antibodies.

Original languageEnglish (US)
Pages (from-to)1198-1202
Number of pages5
JournalBioconjugate Chemistry
Volume25
Issue number7
DOIs
StatePublished - Jul 16 2014
Externally publishedYes

Fingerprint

Binding sites
Nucleotides
Sulfhydryl Compounds
Antibodies
Binding Sites
Butyric acid
Ligands
Antigens
Antibody Binding Sites
Prostate-Specific Antigen
Disulfides
Cysteine
Peptides
Molecules
indolebutyric acid

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Organic Chemistry
  • Pharmaceutical Science
  • Biomedical Engineering
  • Pharmacology
  • Medicine(all)

Cite this

Conjugation of a reactive thiol at the nucleotide binding site for site-specific antibody functionalization. / Alves, Nathan; Mustafaoglu, Nur; Bilgicer, Basar.

In: Bioconjugate Chemistry, Vol. 25, No. 7, 16.07.2014, p. 1198-1202.

Research output: Contribution to journalArticle

@article{6184ca3581224105811d47870862a4ac,
title = "Conjugation of a reactive thiol at the nucleotide binding site for site-specific antibody functionalization",
abstract = "Described here is a UV photo-cross-linking method that utilizes the NBS (nucleotide binding site) for site-specific covalent functionalization of antibodies with reactive thiol moieties (UV-NBSThiol), while preserving antibody activity. By synthesizing an indole-3-butyric acid (IBA) conjugated version of cysteine we site-specifically photo-cross-linked a reactive thiol moiety to antibodies at the NBS. This thiol moiety can then be used as an orthogonally reactive location to conjugate various types of functional ligands that possess a thiol reactive group through disulfide bond formation or reaction with a maleimide functionalized ligand. Our results demonstrate the utility of the UV-NBSThiol method by successfully functionalizing a prostate specific antigen antibody (IgGPSA) with IBA-Thiol and subsequent reaction with maleimide-fluorescein. An optimal UV energy of 0.5-1.5 J/cm2 was determined to yield the most efficient photo-cross-linking and resulted in 1-1.5 conjugations per antibody while preserving antibody/antigen binding activity and Fc recognition. Utilizing the IBA-Thiol ligand allows for an efficient means of site-specifically conjugating UV sensitive functionalities to antibody NBS that would otherwise not have been amenable by the previously described UV-NBS photo-cross-linking method. The UV-NBSThiol conjugation strategy can be utilized in various diagnostic and therapeutic applications with nearly limitless potential for the preparation of site-specific covalent conjugation of affinity tags, fluorescent molecules, peptides, and chemotherapeutics to antibodies.",
author = "Nathan Alves and Nur Mustafaoglu and Basar Bilgicer",
year = "2014",
month = "7",
day = "16",
doi = "10.1021/bc500211d",
language = "English (US)",
volume = "25",
pages = "1198--1202",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Conjugation of a reactive thiol at the nucleotide binding site for site-specific antibody functionalization

AU - Alves, Nathan

AU - Mustafaoglu, Nur

AU - Bilgicer, Basar

PY - 2014/7/16

Y1 - 2014/7/16

N2 - Described here is a UV photo-cross-linking method that utilizes the NBS (nucleotide binding site) for site-specific covalent functionalization of antibodies with reactive thiol moieties (UV-NBSThiol), while preserving antibody activity. By synthesizing an indole-3-butyric acid (IBA) conjugated version of cysteine we site-specifically photo-cross-linked a reactive thiol moiety to antibodies at the NBS. This thiol moiety can then be used as an orthogonally reactive location to conjugate various types of functional ligands that possess a thiol reactive group through disulfide bond formation or reaction with a maleimide functionalized ligand. Our results demonstrate the utility of the UV-NBSThiol method by successfully functionalizing a prostate specific antigen antibody (IgGPSA) with IBA-Thiol and subsequent reaction with maleimide-fluorescein. An optimal UV energy of 0.5-1.5 J/cm2 was determined to yield the most efficient photo-cross-linking and resulted in 1-1.5 conjugations per antibody while preserving antibody/antigen binding activity and Fc recognition. Utilizing the IBA-Thiol ligand allows for an efficient means of site-specifically conjugating UV sensitive functionalities to antibody NBS that would otherwise not have been amenable by the previously described UV-NBS photo-cross-linking method. The UV-NBSThiol conjugation strategy can be utilized in various diagnostic and therapeutic applications with nearly limitless potential for the preparation of site-specific covalent conjugation of affinity tags, fluorescent molecules, peptides, and chemotherapeutics to antibodies.

AB - Described here is a UV photo-cross-linking method that utilizes the NBS (nucleotide binding site) for site-specific covalent functionalization of antibodies with reactive thiol moieties (UV-NBSThiol), while preserving antibody activity. By synthesizing an indole-3-butyric acid (IBA) conjugated version of cysteine we site-specifically photo-cross-linked a reactive thiol moiety to antibodies at the NBS. This thiol moiety can then be used as an orthogonally reactive location to conjugate various types of functional ligands that possess a thiol reactive group through disulfide bond formation or reaction with a maleimide functionalized ligand. Our results demonstrate the utility of the UV-NBSThiol method by successfully functionalizing a prostate specific antigen antibody (IgGPSA) with IBA-Thiol and subsequent reaction with maleimide-fluorescein. An optimal UV energy of 0.5-1.5 J/cm2 was determined to yield the most efficient photo-cross-linking and resulted in 1-1.5 conjugations per antibody while preserving antibody/antigen binding activity and Fc recognition. Utilizing the IBA-Thiol ligand allows for an efficient means of site-specifically conjugating UV sensitive functionalities to antibody NBS that would otherwise not have been amenable by the previously described UV-NBS photo-cross-linking method. The UV-NBSThiol conjugation strategy can be utilized in various diagnostic and therapeutic applications with nearly limitless potential for the preparation of site-specific covalent conjugation of affinity tags, fluorescent molecules, peptides, and chemotherapeutics to antibodies.

UR - http://www.scopus.com/inward/record.url?scp=84904421553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904421553&partnerID=8YFLogxK

U2 - 10.1021/bc500211d

DO - 10.1021/bc500211d

M3 - Article

VL - 25

SP - 1198

EP - 1202

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 7

ER -